Special Edition - InFocus: Life Sciences & Healthcare e-newsletter

A new framework for approval of medicinal products in Europe.

In this special edition of InFocus we review some of the key changes to the European regulatory framework for medicinal products for human use which are set out in Directive 2004/27, Regulation 726/2004 and Directive 2004/24.

Member States were required to implement the directives by 30 October 2005. The Regulation came into effect on 20 November 2005.

About Taylor Wessing's Life Sciences & Healthcare Group

Taylor Wessing's market-leading Life Sciences & Healthcare Group provides a top quality, multi-disciplinary service.  The Group combines Taylor Wessing’s top-rated intellectual property and venture capital lawyers with specialists from our highly acclaimed international corporate, corporate finance, employment and real estate practices.  We advise life sciences and healthcare businesses, those who fund them and those who work for them.

For more information about Taylor Wessing's Life Sciences & Healthcare Group, please click here.

For any legal enquiries, please contact Daniel Pavin or your usual contact at Taylor Wessing.  For any marketing and business development enquiries, please contact Sharon Philbey.